Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1,238.20
-45.40
(-3.54%)
At close: February 28 at 3:30:01 PM GMT+5:30
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ONESOURCE.NS | -- | -- | -- | -- |
| S&P 500 | 16.01% | 7.37% | 10.68% | 14.19% |
Related Tickers
CONCORDBIO.NS Concord Biotech Limited
1,496.10
-5.86%
BCAX Bicara Therapeutics Inc.
13.30
+7.61%
RLYB Rallybio Corporation
0.7223
-2.39%
IMTX Immatics N.V.
4.3800
0.00%
PTGX Protagonist Therapeutics, Inc.
37.59
+3.44%
ENSC Ensysce Biosciences, Inc.
5.39
+2.67%
SION Sionna Therapeutics, Inc.
13.77
-6.71%
NKTR Nektar Therapeutics
0.8400
+5.50%
RIGL Rigel Pharmaceuticals, Inc.
23.06
+5.88%
ALLO Allogene Therapeutics, Inc.
1.9500
0.00%